Abstract
Over last 3 decades, percutaneous coronary interventions (PCI) has transformed management of obstructive coronary artery disease (CAD). Commenced with balloon dilation i.e. plain old balloon angioplasty (POBA) of severe obstructive CAD lesions, gradually evolved into stenting started with bare-metal stents (BMS), initially first-generation (stain-less steel) and now contemporary second-generation BMS (cobalt-chromium with thinner struts). BMS was rapidly superseded by drugeluting stents (DES); at first with first-generation (paclitaxeleluting, taxus; and sirolimus-eluting, cypher) now with secondgeneration (zotarolimus-eluting, endeavor; and everolimuseluting, xience) and with ongoing refinements thirdgeneration drug-eluting stents (with biodegradable polymers, polymer-free and biodegradable stents on the basis of poly-Llactide or magnesium) are undergoing trials and many are available for use in contemporary practice.
Highlights
Over last 3 decades, percutaneous coronary interventions (PCI) has transformed management of obstructive coronary artery disease (CAD)
Commenced with balloon dilation i.e. plain old balloon angioplasty (POBA) of severe obstructive CAD lesions, gradually evolved into stenting started with bare-metal stents (BMS), initially first-generation [1] and contemporary second-generation BMS
BMS was rapidly superseded by drugeluting stents (DES); at first with first-generation with secondgeneration and with ongoing refinements thirdgeneration drug-eluting stents are undergoing trials and many are available for use in contemporary practice
Summary
Over last 3 decades, percutaneous coronary interventions (PCI) has transformed management of obstructive coronary artery disease (CAD). Corresponding author: Abdullah Mohammed Shehab, Professor of Cardiology, Consultant Cardiologist, Faculty of Medicine and Health sciences, UAE University, Al Noor Hospital, Al Ain, UAE, Tel: +97137667666; E-mail: a.shehab@uaeu.ac.ae Commenced with balloon dilation i.e. plain old balloon angioplasty (POBA) of severe obstructive CAD lesions, gradually evolved into stenting started with bare-metal stents (BMS), initially first-generation (stain-less steel) [1] and contemporary second-generation BMS (cobalt-chromium with thinner struts).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.